|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9700 AUD | 0.00% |
|
-3.00% | -10.60% |
| 01-19 | Orthocell posts quarterly revenue of A$3.2 million | RE |
| 01-16 | Orthocell Finalizes Agreement With Biotechnology Company | MT |
| Capitalization | 263M 180M 153M 142M 133M 248M 16.47B 1.62B 643M 7.78B 674M 661M 28.48B | P/E ratio 2026 * |
-
| P/E ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise value | 219M 150M 128M 119M 111M 207M 13.74B 1.35B 536M 6.49B 562M 551M 23.75B | EV / Sales 2026 * |
15.8x | EV / Sales 2027 * | 9.42x |
| Free-Float |
75.86% | Yield 2026 * |
-
| Yield 2027 * | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 week | -3.00% | ||
| Current month | -10.60% | ||
| 1 month | -7.62% | ||
| 3 months | -23.32% | ||
| 6 months | -29.45% | ||
| Current year | -10.60% |
| 1 week | 0.95 |  | 1.02 |
| 1 month | 0.95 | | 1.16 |
| Current year | 0.95 | | 1.16 |
| 1 year | 0.95 | | 1.79 |
| 3 years | 0.32 | | 1.79 |
| 5 years | 0.3 | | 1.79 |
| 10 years | 0.1 | | 1.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Hao Zheng
CTO | Chief Tech/Sci/R&D Officer | - | 21/03/2006 |
Paul Anderson
CEO | Chief Executive Officer | 60 | 21/03/2006 |
Tony Macintyre
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Anderson
BRD | Director/Board Member | 60 | 21/03/2006 |
Ravi Thadhani
BRD | Director/Board Member | 60 | 08/03/2023 |
| Chairman | - | 01/06/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -3.00% | -39.94% | +139.51% | 180M | |
| +0.50% | +2.37% | +11.29% | +7.71% | 240B | |
| +0.40% | -2.87% | -13.87% | +104.78% | 186B | |
| -0.81% | +0.08% | -1.68% | -12.51% | 170B | |
| -0.46% | +1.40% | -8.99% | +100.11% | 135B | |
| -1.26% | -5.94% | -19.86% | -11.12% | 57.83B | |
| -0.82% | -0.06% | +22.31% | +6.50% | 49B | |
| -0.82% | -4.28% | -9.15% | -11.09% | 39.3B | |
| -1.52% | -2.05% | +3.24% | +8.78% | 37.19B | |
| +0.97% | -0.75% | -6.23% | +22.64% | 37.3B | |
| Average | -0.09% | -1.63% | -6.29% | +35.53% | 95.24B | |
| Weighted average by Cap. | +0.39% | -0.39% | -2.00% | +34.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.9M 9.5M 8.09M 7.51M 7.04M 13.11M 870M 85.74M 33.97M 411M 35.63M 34.9M 1.5B | 24.1M 16.47M 14.02M 13.02M 12.21M 22.73M 1.51B 149M 58.91M 713M 61.77M 60.5M 2.61B |
| Net income | - | - |
| Net Debt | -43.7M -29.87M -25.42M -23.61M -22.14M -41.22M -2.74B -270M -107M -1.29B -112M -110M -4.73B | -36.1M -24.67M -21M -19.5M -18.29M -34.05M -2.26B -223M -88.24M -1.07B -92.52M -90.63M -3.91B |
More financial data
* Estimated data
Employees
-
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 0.9700 $ | 0.00% | 224,868 |
| 22/01/26 | 0.9700 $ | -3.00% | 549,265 |
| 21/01/26 | 1.000 $ | +1.01% | 1,031,275 |
| 20/01/26 | 0.9900 $ | -1.00% | 394,019 |
| 19/01/26 | 1.000 $ | 0.00% | 551,163 |
Delayed Quote Australian S.E., January 23, 2026 at 09:11 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9700AUD
Average target price
1.330AUD
Spread / Average Target
+37.11%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OCC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition